230 related articles for article (PubMed ID: 31963614)
1. Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study.
Di Sotto A; Irannejad H; Eufemi M; Mancinelli R; Abete L; Mammola CL; Altieri F; Mazzanti G; Di Giacomo S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963614
[TBL] [Abstract][Full Text] [Related]
2. Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention.
Di Sotto A; Di Giacomo S; Rubini E; Macone A; Gulli M; Mammola CL; Eufemi M; Mancinelli R; Mazzanti G
Cells; 2020 Apr; 9(4):. PubMed ID: 32252311
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitizing Properties of β-Caryophyllene and β-Caryophyllene Oxide in Combination with Doxorubicin in Human Cancer Cells.
DI Giacomo S; DI Sotto A; Mazzanti G; Wink M
Anticancer Res; 2017 Mar; 37(3):1191-1196. PubMed ID: 28314281
[TBL] [Abstract][Full Text] [Related]
4. Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein.
Nagai K; Fukuno S; Miura T; Uchino Y; Sehara N; Konishi H
Pharmazie; 2020 Oct; 75(10):510-511. PubMed ID: 33305727
[TBL] [Abstract][Full Text] [Related]
5. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
Achari C; Reddy GV; Reddy TC; Reddanna P
Med Chem; 2011 Sep; 7(5):432-42. PubMed ID: 21801152
[TBL] [Abstract][Full Text] [Related]
6. Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells.
Di Giacomo S; Mariano A; Gullì M; Fraschetti C; Vitalone A; Filippi A; Mannina L; Scotto d'Abusco A; Di Sotto A
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771097
[No Abstract] [Full Text] [Related]
7. Understanding dihydro-β-agarofuran sesquiterpenes from Tripterygium hypoglaucum as the modulators of multi-drug resistance in HepG2/Adr cells.
Yang T; Wang S; Zheng H; Wang L; Liu D; Chen X; Li R
Biochem Biophys Res Commun; 2019 Jan; 508(3):742-748. PubMed ID: 30528235
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis.
Di Giacomo S; Gullì M; Facchinetti R; Minacori M; Mancinelli R; Percaccio E; Scuderi C; Eufemi M; Di Sotto A
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745837
[TBL] [Abstract][Full Text] [Related]
10. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
11. Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.
Kanzaki A; Takebayashi Y; Ren XQ; Miyashita H; Mori S; Akiyama S; Pommier Y
Mol Cancer Ther; 2002 Dec; 1(14):1327-34. PubMed ID: 12516966
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.
Carabias P; Espelt MV; Bacigalupo ML; Rojas P; Sarrias L; Rubin A; Saffioti NA; Elola MT; Rossi JP; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
Cell Death Dis; 2022 Jan; 13(1):79. PubMed ID: 35075112
[TBL] [Abstract][Full Text] [Related]
13. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
14. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
Ye CG; Wu WK; Yeung JH; Li HT; Li ZJ; Wong CC; Ren SX; Zhang L; Fung KP; Cho CH
Cancer Lett; 2011 May; 304(2):90-6. PubMed ID: 21377266
[TBL] [Abstract][Full Text] [Related]
17. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
18. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Lehne G; De Angelis P; Clausen OP; Rugstad HE
Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps.
Di Giacomo S; Briz O; Monte MJ; Sanchez-Vicente L; Abete L; Lozano E; Mazzanti G; Di Sotto A; Marin JJG
Arch Toxicol; 2019 Mar; 93(3):623-634. PubMed ID: 30659321
[TBL] [Abstract][Full Text] [Related]
20. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C
Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
